Ammunition

Wuhan Ammunition Life-tech Co., Ltd. was established in January 2015. It is a high-tech enterprise focusing on the research, registration, production, and sales of non-invasive detection products for early-stage malignant tumors with high incidence. The company's headquarters, research and development center, manufacturing center, and medical testing laboratory are located in Wuhan Optics Valley Biocity. As one of the leading enterprises in the new generation of tumor detection products, Aimi Sen is committed to the global promotion of cancer detection technologies. Combining epigenetics, bioinformatics, clinical big data, and artificial intelligence analysis, and adhering to the product concept of "early, precise, convenient, and affordable," Aimi Sen has pioneered the construction of a new generation of tumor screening and detection technology platforms and product systems. It has launched a series of early non-invasive detection products covering high-incidence cancers such as digestive system tumors, gynecological tumors, urinary system tumors, and pan-cancer types. These products enable early, non-invasive, and accurate tumor detection, reducing the incidence and mortality rates of cancer, nipping cancer in the bud, and safeguarding human life and health.